2008
- Club Penguin and its Players Help Make the Holidays Brighter for Kids in Need
- Business Wire - December 25, 2008
- KELOWNA, British Columbia--Two-and-a-half million Club PenguinTM (clubpenguin.com) players embraced the spirit of the season and displayed their passion for helping others this holiday by participating in a unique online giving opportunity that let them donate virtual coins to support real world causes. The second annu
- "Homophobe" Rick Warren Seeks Redemption at AHF's "Out of the Closet," Says AHF
- Business Wire - December 23, 2008
- --Press Teleconference TODAY at 2:30pm (PST) LOS ANGELES--AIDS Healthcare Foundation: What: Press Teleconference Call AHF, owner of Out of the Closet reacts to West Hollywood visit by Rick Warren When: TODAY Tuesday, December 23rd 2:30 pm Pacific Time Who: Michael Weinstein, President, AIDS Healthcare Foundation Ho
- Court Orders Schwarzenegger Administration to Enforce HIV/AIDS Law, Says AHF
- Business Wire - December 23, 2008
- -- Superior Court Judgment Commands California Department of Health to Comply with Landmark 2002 Law Providing Care for HIV-Infected Individuals, Compels State to Report Within 120 Days on Actions Taken LOS ANGELES--The Superior Court of California, County of Los Angeles has entered a judgment and will issue a writ ord
- Research and Markets: a Report on Pricing and Reimbursement of Fixed-Dose Combination Drugs in the United States
- Business Wire - December 22, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/98a1a9/pricing_and_re imbu) has announced the addition of Decision Resources, Inc. s new report Pricing and Reimbursement of Fixed-Dose Combination Drugs in the United States to their offering. Fixed-dose combinations (FDCs) of prescripti
- Progen Pharmaceuticals Limited and Avexa Limited Agree to Merge
- Business Wire - December 21, 2008
- -- Conference Call Scheduled for Today at 11:00 am (Sydney time) * Creates one of Australia s leading biotechnology companies * Balanced portfolio of infectious disease and oncology assets with a Phase III HIV program * Progen shareholders to have the option to participate in AUD $20M buyback * Combined entity will hav
- GIS AIDS Alaska Native Health Study
- Business Wire - December 19, 2008
- -- Alaska Tribal Health Consortium uses innovative technology to analyze native health issues across the state. ANCHORAGE, Alaska--The Alaska Native Tribal Health Consortium will publish a study in January 2009 which utilizes Geographic Information Systems (GIS) to analyze incidents of disease and injury across Alaska
- BioAlliance Pharma's Innovation Rewarded
- Business Wire - December 19, 2008
- -- BioAlliance Pharma s Team receives the French Engineer of the Year Award PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that Dominique Costantini MD (President of the company s Ex
- Sierra Leone AIDS Director Praises AHF for "One Million Tests/World AIDS Day 2008" Campaign
- Business Wire - December 19, 2008
- -- Letter of Appreciation from Director of National HIV/AIDS Council and Secretariat Acknowledges Successful Collaboration Which Resulted in 23,063 People Being Tested for HIV in Sierra Leone in the Week Leading Up to December 1, 2008 LOS ANGELES--AIDS Healthcare Foundation (AHF) is proud to announce that it has receiv
- Starbucks and (RED) Debut the (STARBUCKS)RED Card to Help Save Lives in Africa
- Business Wire - December 18, 2008
- -- New Product Introduction Builds on Momentum from First Two Weeks of Sales of the (STARBUCKS)RED EXCLUSIVE Beverages Which Have Generated Contributions Equal to More Than 1.4 Million Daily Doses of Lifesaving Antiretroviral Medicine SEATTLE--Starbucks Coffee Company (Nasdaq: SBUX) announced today that beginning Janua
- AIDS Nobel Laureate Joins Viral Genetics: Luc Montagnier Will Advise Firm Developing Immune-Based Therapies
- Business Wire - December 18, 2008
- SAN MARINO, Calif.--Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine and the co-discoverer of the HIV virus, has joined Viral Genetics (OTCBB: VRAL), a biotechnology company that discovers and develops immune-based therapies. Montagnier joins a current team of esteemed advisors with diverse expertise to h
- Researchers Successfully Used the 454 Sequencing System for Sensitive Detection of HIV Tropism
- Business Wire - December 18, 2008
- BRANFORD, Conn.--454 Life Sciences, a Roche company, announced today that a team of researchers from the BC Centre of Excellence in HIV/AIDS and the University of British Columbia, Canada have used the Genome Sequencer FLX system to monitor low frequency HIV variants from human samples in a recent study. The preliminar
- Zimbabwe's MDC Thanks AHF for "One Million Tests/World AIDS Day 2008" Leadership
- Business Wire - December 17, 2008
- --Letter from Movement for Democratic Change - South African Province Chairman Acknowledges Successful Collaboration, Expresses ...Hope That This Will Lead to a Positive Change as Far as Dealing with HIV and AIDS Issues by Both Our Leadership and the People That We Lead LOS ANGELES--AIDS Healthcare Foundation (AHF) is
- Orange County’s Mariners Church Asks Its 10,000 Members to Rethink Christmas by Buying "Give" Cards for the Poor and Needy
- Business Wire - December 17, 2008
- -- Christmas Different Program Will Raise More than $100,000 By Selling Give Cards that Allow Recipients to Pick the Benefiting Charity --Mariners Church: WHAT: Mariners Church is asking its 8,000 to 10,000 members to entirely rethink Christmas in 2008 in the areas of gift-giving and volunteering to support the poor an
- High Growth Forecasted for the World Monoclonal Antibody Based Products Market
- Business Wire - December 16, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Diagnostic equipment industry is available in its catalogue. World Monoclonal Antibody Based Products Market http://www.reportlinker.com/p098405/World-Monoclonal-Antibody-Bas ed-Products--Market.html This report analyzes the worldwide
- High Growth Reported for the World Clinical Chemistry Analyzers & Reagents Market
- Business Wire - December 16, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Laboratory equipment industry is available in its catalogue. World Clinical Chemistry Analyzers & Reagents Market http://www.reportlinker.com/p098408/World-Clinical-Chemistry-Anal yzers--Reagents-Market.html This report analyzes t
- Get a Deep Insight into the World Gene Therapy Market
- Business Wire - December 16, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Gene Therapy Market http://www.reportlinker.com/p098244/World-Gene-Therapy--Market.ht ml This report analyzes the world market for Gene Therapy in Millions of
- Zacks Analyst Blog Highlights: Sara Lee Corporation, Burger King Holdings, Inc., McDonald's, Gilead Sciences, Inc., and ICICI Bank Limited.
- Business Wire - December 16, 2008
- CHICAGO--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sara Lee Corporation (NYSE: SLE), Burger King Holdings, Inc. (NYSE: BKC)
- Macro International Awarded Contract to Serve as the Data Coordinating Center for CDC's HIV/AIDS Data
- Business Wire - December 15, 2008
- CALVERTON, Md.--Macro was recently awarded a contract with the Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention to be the Data Coordinating Center for the National HIV Behavioral Surveillance System (NHBS) and the Medical Monitoring Project (MMP). This $4.7 million, 3-year contract enab
- AIDS Healthcare Foundation Awarded Full NCQA Reaccreditation for Effective Disease Management Program
- Business Wire - December 15, 2008
- FT. LAUDERDALE, Fla.--AIDS Healthcare Foundation (AHF), the nation s largest non-profit HIV/AIDS organization, which operates free AIDS treatment clinics in the U.S., Africa, Central America and Asia, has been surveyed by the National Committee for Quality Assurance (NCQA) for reaccreditation and again awarded Full Acc
- Cellectis Meets the 20 Meganucleases Annual Capacity Milestone
- Business Wire - December 12, 2008
- -- Update on Strategy Implementation and Milestone Achievement PARIS--Biocitech Life Sciences Park, France - Cellectis S.A. (Alternext: ALCLS), the genome engineering company for therapeutic, life science research and other biotechnology industries, announced today the achievement of a key milestone set at the time of
- Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS(R) (raltegravir) in Adult Patients Previously Untreated for HIV-1
- Business Wire - December 12, 2008
- WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co. , Inc. today announced that the U.S. Food and Drug Administration ( FDA ) has accepted the supplemental New Drug Application (sNDA) filing for ISENTRESS(R) (raltegravir) Tablets for standard review. The Company is seeking United St
- WOMEN'S WAY Regional Report Uncovers Stagnant Socioeconomic Status & Declining Conditions for Women
- Business Wire - December 12, 2008
- -- 2008 Change of Pace Reveals Continuing Wage Gaps, Worsening Poverty, Rising Female Incarceration PHILADELPHIA--From the workplace to the home, from health care to the justice system, a report from WOMEN S WAY, the nation s oldest and largest women s funding federation, reveals stagnant socioeconomic standing and wor
- Announcement by Progenics Pharmaceuticals under Nasdaq Marketplace Rules
- Business Wire - December 11, 2008
- TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it fails to comply with Nasdaq s audit committee requirements. As a result of Mr. Paul F. Jacobson s previously-announced resignation from the Company s Board of Director
- Allsup Place Offers Unique, Customizable Community for Individuals with Disabilities
- Business Wire - December 9, 2008
- -- Online community allows participants to track their SSDI claims, learn more about their disability, find helpful resources, join online forums and more BELLEVILLE, Ill.--Allsup today introduced Allsup PlaceSM, a dynamic, free online community providing comprehensive resources, forums and information for individuals
- Ramsell Holding Corporation Founder Sylester Flowers Honored by "Get Screened Oakland" for HIV/AIDS Community Service
- Business Wire - December 9, 2008
- -- Second Annual Ceremony Held at Oakland City Hall on World AIDS Day OAKLAND, Calif.--Ramsell Holding Corporation founder Sylester Flowers was honored by Get Screened Oakland on World AIDS Day - December 1, 2008, for his commitment to serving those in the community infected with the HIV/AIDS virus. The theme of the ev
- PolyMedix To Present At HIV DART 2008 on Novel Antimicrobial Compounds for Treatment of Drug Resistant Tuberculosis
- Business Wire - December 9, 2008
- -- December 10, 2008, Wyndham Grand Hotel, Puerto Rico RADNOR, Pa.--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make a poster presentation at this year s HIV DART
- Focus on the World Diabetes Diagnostics Market
- Business Wire - December 9, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Digestive diseases industry is available in its catalogue. World Diabetes Diagnostics Market http://www.reportlinker.com/p092478/World-Diabetes-Diagnostics-Ma rket.html This report analyzes the worldwide markets for Diabetes Diagnosti
- ViroStatics' President and CEO, Dr. Franco Lori, to address HIV DART 2008 in Puerto Rico
- Business Wire - December 8, 2008
- SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced the Company s President and CEO, Dr. Franco Lori, will be speaking at the HIV DART 2008 conference in Puerto Rico on Wednesday, December 10th. Dr. Lori s presentation, Development of VS411, a Virostatic Drug Fixed Dose Combination (FDC) Designed to
- Nutra Pharma Receives Clinical Drug Supply Contract
- Business Wire - December 8, 2008
- BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, has received a contract from Irish biotechnology firm, Celtic Bio
- GeoVax Labs and VGX International Announce Agreement at the Las Vegas "International Society of DNA Vaccines" Conference
- Business Wire - December 8, 2008
- -- GeoVax s Dr. Harriet Robinson - a key conference speaker on the State of the Art Session VGXI Inc. s Robert J. Juba - speaker on Manufacturing a High Concentration Multi-Component DNA Vaccine International Society of DNA Vaccines Conference LAS VEGAS--GeoVax Labs, Inc. (OTCBB:GOVX), an Atlanta-based biopharmaceutica
- Blue Cross Blue Shield of Massachusetts Foundation Awards $768,387 in Grants to Address Health Care Disparities
- Business Wire - December 8, 2008
- BOSTON--The Blue Cross Blue Shield of Massachusetts Foundation has awarded $768,387 in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental illness, and sexual orientation. Eight organizations will receive
- Profectus BioSciences Awarded $21.6 Million in NIH Contracts to Develop a HIV Preventative and a HIV Therapeutic Vaccine
- Business Wire - December 8, 2008
- BALTIMORE--Profectus BioSciences, Inc. (Profectus), a biopharmaceutical company that develops proprietary prime/boost vaccines and small molecule to treat and prevent viral infections and cancers, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institu
- Nike Foundation Calls on Global HIV-Prevention Initiatives to Focus on Girls
- Business Wire - December 5, 2008
- Marked by a New Global Partnership and a High-Level Meeting on Girls and HIV in Senegal , World AIDS Week efforts Bring Girls to the Center of the HIV Response BEAVERTON, Ore.--Against the backdrop of World AIDS Week, the Nike Foundation has launched a global effort with government partners to put adolescent girls in d
- Focus on the World Condoms Market
- Business Wire - December 4, 2008
- NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Condoms Market http://www.reportlinker.com/p090642/World-Condoms-Market.html This report analyzes the worldwide markets for Condoms in Million Units and Mi
- Court Orders California to Aid HIV Patients
- Business Wire - December 4, 2008
- -- Superior Court Rules California Has Failed to Comply with Landmark 2002 Law for Care of HIV-Infected; Six Years after Legislature First Passed AB 2197, Implementation of Lifesaving HIV Care Bill is at a Standstill LOS ANGELES--AIDS Healthcare Foundation: What: Press Teleconference Call Court Orders California to Com
- Key Challenges and Issues facing the World Immunoassay Instruments Market
- Business Wire - December 4, 2008
- NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Immunoassay Instruments Market http://www.reportlinker.com/p090674/World-Immunoassay-Instruments -Market.html This report analyzes the worldwide markets fo
- Data Demonstrating Significant Efficacy of Viread(R) in Treating Chronic Hepatitis B Published in New England Journal of Medicine
- Business Wire - December 3, 2008
- -- Important Findings for Treatment of One of World s Most Common Life-Threatening Liver Diseases -- FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq: GILD) today announced the publication of detailed 48-week data from two Phase III pivotal clinical trials evaluating the safety and efficacy of its once-daily
- CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases
- Business Wire - December 3, 2008
- SANTA FE, N.M.--CytoDyn, Inc. (Pink Sheets:CYDY) has rounded out its European patent portfolio with new patents in Ireland , France , Switzerland , Austria ,
- "The Broad-Spectrum Treatment of Biological Weapons and Emerging Pandemic Threats Report" released by Aethlon Medical
- Business Wire - December 3, 2008
- SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that it has released a report entitled: The Broad-Spectrum Treatment of Biological Weapons and Emerging Pandemic Threats. The report is available to be accessed online at: www.aethlonmedical.com/pdfs/BroadSpectrumTreament120308.pdf Summary of the Report
- Article in The Pink Sheet Describes Managed Care Payers' Expanding Healthcare Value Scrutinization of New Oncology, HIV, and Rare Disease Drugs
- Business Wire - December 2, 2008
- -- Article highlights The Bruckner Group s industry-leading expertise helping pharma and biotech companies develop new drugs that address payers healthcare value needs WAKEFIELD, Mass.--The Pink Sheet, one of the leading publications in the pharmaceutical and biotechnology industries, published an article in its Decemb
- Examine the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
- Business Wire - December 2, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) http://www.reportlinker.com/p097962/The-Clinical-Laboratory-Servi ces-
- LabKey Server v8.3 Now Available
- Business Wire - December 2, 2008
- -- Latest Version Provides Large-Scale Collaborative Research Projects with Better Tools for Integrating, Sharing and Analyzing Complex Biological Data SEATTLE--LabKey Software, a leading provider of open source software that enables teams of researchers to pursue large-scale, collaborative projects, announced the rele
- Stanford Scientists' Discovery of Virus in Lemur Could Shed Light on AIDS
- Business Wire - December 1, 2008
- STANFORD, Calif.--The genome of a squirrel-sized, saucer-eyed lemur from Madagascar may help scientists understand how HIV-like viruses coevolved with primates, according to new research from the Stanford University School of Medicine. The discovery, to be published online on Dec. 1 in the Proceedings of the National A
- Webroot Announces Charitable Giving Program for Non-Profits
- Business Wire - December 1, 2008
- --Highlights Two Beneficiaries of Giving Program in Honor of National AIDS Awareness Day BOULDER, Colo.--Webroot, a leading provider of security software for the consumer, enterprise and SMB markets, today announced the introduction of The Webroot(R) Charitable Giving Program for providing support to the areas of child
- W Hotels Worldwide Announces First and Only Hotel Partnership With (RED)TM's Groundbreaking New Online Music Magazine: (RED)WIRE TM
- Business Wire - December 1, 2008
- --Partnership will Provide W Hotel Guests and Local Loyalists with Insider Access to a World of Exclusive Music and Entertainment while Benefiting the Global Fund NEW YORK--WORLD AIDS DAY - W Hotels Worldwide today announced that it will be the official hotel partner of (RED)WIRE, the groundbreaking new online music ma
- OraSure Technologies Supports Global and Domestic Rapid HIV Testing Initiatives for World AIDS Day
- Business Wire - December 1, 2008
- BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today announced its support of rapid HIV testing initiatives taking place in more than 20 states in the U.S. and several countries globally, in recognition of World AIDS Day, commemorated annually on December 1st. Ora
- IAVI Launches Video Commitments Project on World AIDS Day 2008
- Business Wire - December 1, 2008
- --Testimonials to Help Raise Global Support for AIDS Vaccine Development NEW YORK--On the 20th anniversary of World AIDS Day, the International AIDS Vaccine Initiative (IAVI) invites individuals from around the world to show their support for the development of an AIDS vaccine by contributing their voices to a new gall
- ACP Recommends Routine HIV Screening for All Patients
- Business Wire - December 1, 2008
- -- December 1 is World AIDS Day PHILADELPHIA--On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the Annals of Internal Medicine Web site at www.annals.or
- AIDS Day: Successful Global HIV Testing Campaign to Test 1M People Marches On
- Business Wire - November 30, 2008
- Enthusiastic Response Greets Worldwide HIV Testing Campaign Led By AHF; 1,000 Organizations in 72 Countries Team Together to Test One Million People Worldwide November 26th – December 1st for Week of World AIDS Day LOS ANGELES--(BUSINESS WIRE)--As part of its global World AIDS Day effort to test one million people for
- AHF Offers Day of Free HIV Testing at Wilton Manors 'Out of the Closet' to Mark World AIDS Day
- Business Wire - November 29, 2008
- As Rate of New Infections in Florida Soars to More Than Sixty Percent Higher than the National Average, AHF s World AIDS Day Campaign Highlights Need for Increased Prevention, Education and Testing Efforts in the State—Now Ranked Second in the Nation in Reported AIDS Cases Wilton Manors Event is Part of AHF s Global O
- 24-Hour Free HIV Testing Marathon at AHF's Hollywood 'Out of the Closet' Store Marks World AIDS Day
- Business Wire - November 27, 2008
- LA s Power 106FM Radio Teams With AHF in Night of Round-the-Clock Free Rapid HIV Testing Starting Saturday, November 29th at 4:00pm Hollywood Event is Part of AHF s Global One Million Tests Campaign; 1,000 Organizations in 72 Countries Will Test One Million People for HIV by Monday--World AIDS Day LOS ANGELES--(BUSINES
- Kaiser Permanente Clinical Trials Patients Celebrate World AIDS Day with Another Year of Good Health
- Business Wire - November 27, 2008
- PASADENA, Calif.--Twenty years after the first World AIDS Day, there are stories of survival and hope. Eduardo, Herbert, and Guy can celebrate another year of good health, thanks to their participation in Kaiser Permanente Southern California s HIV/AIDS Research Trials (H.A.R.T.) program. In 2007-2008, over 220 HIV inf
- AHF: Lancet's Africa AIDS Study Shows Global Testing Woefully Under-funded
- Business Wire - November 26, 2008
- AHF s Current World AIDS Day One Million Tests Global Campaign Provides Roadmap for Collaborative Scale Up of Testing; 1,000 Groups in 72 Countries to Test 1M People by Monday US Largest AIDS Group Calls on Global Bodies Such As the World Health Organization , Global Fund and PEPFAR to Change Course and Direct More Fun
- U.S. Lutheran Bishops Agree to HIV and AIDS Testing
- Business Wire - November 26, 2008
- CHICAGO--In response to the development of an HIV and AIDS strategy by the Evangelical Lutheran Church in America (ELCA), the ELCA Conference of Bishops agreed to the presence of health screeners at its March 5-10, 2009, meeting for the purpose of providing HIV and AIDS testing to all members. The ELCA Conference of Bi
- The Flowers Heritage Foundation Hosts Third Annual "Don't Turn Your Back on AIDS" Student Art Competition Awards and Auction Promoting AIDS Awareness in Bay Area High Schools
- Business Wire - November 26, 2008
- --EVENT DETAILS WHAT: The third annual Flowers Heritage Foundation Don t Turn your back on AIDS program provides an interactive environment where high school students learn information regarding teen HIV/AIDS infections, risks and prevention. Participants are given orientations by AIDS outreach educators, and are chall
- Starbucks Holiday Beverages Turn (RED)(TM) Nov. 27
- Business Wire - November 26, 2008
- -- On World AIDS Day, Monday, Dec. 1, Starbucks Extends Contribution for Every Hand-Crafted Beverage Purchased SEATTLE--Starbucks Coffee Company (Nasdaq: SBUX) announced today the first (STARBUCKS)RED EXCLUSIVE beverages will be available in participating stores in the U.S. and Canada from Thursday, November 27 thr
- AIDS Advocates Call on WHO for Action: Stop Harmful Single-Dose Treatment for Expectant Mothers and Infants
- Business Wire - November 25, 2008
- -- A Letter Sent Today to General Director Dr. Margaret Chan, Signed by AHF-Led Coalition of Hundreds, Urges Immediate Update of WHO Recommendations to End Sub-Standard Treatment Practice Widely-Known to Cause Drug Resistance and Endanger Lives LOS ANGELES--As World AIDS Day 2008 approaches, a coalition of hundreds of
- Pfizer's Novel HIV/AIDS Treatment SELZENTRY(TM) Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients
- Business Wire - November 25, 2008
- NEW YORK--The U.S. Food and Drug Administration ( FDA ) has granted SELZENTRY(TM) (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals. SELZENTRY was originally granted accelerated conditional approval in August 2007 based on 24
- Goal: One Million HIV Tests! 1,000 Organizations in 72 Countries to Test One Million People November 26th - December 1st
- Business Wire - November 25, 2008
- -- AHF Kicks Off Ambitious Global Testing Campaign for Week of World AIDS Day LOS ANGELES--As part of a groundbreaking global effort to test one million people for HIV, AIDS Healthcare Foundation (AHF), the largest AIDS group in the US which currently provides medical care and services to more than 86,000 individuals i
- MillerCoors and Matthew Shepard Foundation Partner to Help Erase Hate
- Business Wire - November 25, 2008
- GOLDEN, Colo.--MillerCoors has teamed up with Judy Shepard to support the Matthew Shepard Foundation (MSF) and its ongoing commitment to ensure that dealing with hate is a top priority in our schools and workplaces. MillerCoors, a national sponsor of MSF, announced it will match 100% of the first $10,000 in donations t
- Allion Healthcare to Present at Piper Jaffray Healthcare Conference
- Business Wire - November 25, 2008
- -- Piper Jaffray Healthcare Conference MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Piper Jaffray Healthcare Conference at 12:30 p.m. (Eastern) on Tuesday, December 2, 2008 at the New York Palace Hotel in New York, New York. Mike Moran, Allion s Chairman, President and Ch
- National AIDS Memorial to Observe World AIDS Day with "Coming of Age with AIDS" Theme
- Business Wire - November 25, 2008
- -- Family with HIV/AIDs Are Featured Speakers SAN FRANCISCO--The 15th annual World AIDS Day remembrance ceremony will be held on Monday, December 1st from 12:00 p.m. to 1:00 p.m. at the National AIDS Memorial Grove in the Golden Gate Park. This year s event marks the 27th year in the fight against AIDS and commemoratin
- UnitedHealthcare Issues Statement Regarding World AIDS Day
- Business Wire - November 25, 2008
- -- On World AIDS Day, Consider the Impact on Youth CYPRESS, Calif.--The following is an opinion editorial provided by Dr. Sam Ho, executive vice president and chief medical officer of UnitedHealthcare: With improved drugs, proper care and treatment, people with HIV are living longer and stronger lives while caring for
- Kaiser Permanente Announces $300,000 in Southern California Grants, Research, and Theatre Spotlight World AIDS Day
- Business Wire - November 24, 2008
- --$1 Million Awarded Statewide Underscores Long-Term Commitment To Community Partnerships PASADENA, Calif.--Kaiser Permanente announced today that 38 nonprofit organizations from Kern to San Diego will receive grants totaling more than $300,000 to help fund a wide range of services for people with HIV and AIDS, includi
- Avexa Completes Recruitment for First Component of ATC Phase III Trial
- Business Wire - November 24, 2008
- -- Phase IIb Extension Study Reaches 96 Week Milestone MELBOURNE, Australia--Australian biotechnology company Avexa (ASX:AVX) today announced that it has completed recruitment of the first 160 patients for the two-dose component of its Phase III trial for apricitabine (ATC), with over 300 patients in the screening or d
- Healthcare & Waste Disposal Workers: Don't Get Stuck!
- Business Wire - November 24, 2008
- --Workplace & Careers IV Incredibly, healthcare workers report suffering over one million injuries from conventional needles and sharps (e.g., syringes, scalpels) every year; with as many as five million needle-stick injuries gone unreported. These accidental exposures can have serious consequences, from the spread
- Argos Therapeutics Completes $35.2 Million Series C Financing
- Business Wire - November 21, 2008
- -- Supports Continued Progress in Arcelis™ Personalized Immunotherapy Programs in HIV, Oncology and Novel Autoimmune Candidate Development DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the closing of the second and final tranche of a $35.2 million Series C financing from a top-tier, international sy
- US Should Spend $200M on HIV Tests for Ten Million People as Domestic Testing Falls Short of CDC Goals
- Business Wire - November 20, 2008
- -- AHF to Unveil Its “One Million Tests” Campaign, an Ambitious Global Effort to Test One Million People Worldwide for HIV During Observation of World AIDS Day 2008 (Dec 1st) 1,000 Organizations Worldwide—Including 99 Partners in the US—Will Test a Combined Total of One Million Individuals for HIV Between Nov 26th – De
- Ardea Biosciences to Present at the 20th Annual Piper Jaffray Healthcare Conference
- Business Wire - November 20, 2008
- SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, Ardea s president and chief executive officer will present at the 20th Annual Piper Jaffray Healthcare Conference. Presentation details are as follows: Date: | Tuesday, December 2, 2008 Time: | 9:00 a.m. Eastern Standard Time
- Learn about the World Molecular Diagnostics Market
- Business Wire - November 20, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Molecular Diagnostics Market http://www.reportlinker.com/p090566/World-Molecular-Diagnostics-M arket.html This report analyzes the worldwide markets for Molecu
- Seven Investigator-Initiated Clinical Studies Announced
- Business Wire - November 19, 2008
- SAN DIEGO--Cytori (NASDAQ:CYTX) announced today it has been informed that seven new investigator-initiated clinical studies in Japan using adipose-derived regenerative cells have been approved by local ethical committees. The approvals are at leading academic university hospitals and include a diverse group of therapeu
- Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.
- Business Wire - November 19, 2008
- -- Completion of M&A in Response to Proven Success of V-Clip s Mechanism of Action to Further Research in HIV/AIDS & Other Immune Based Diseases SAN MARINO, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today announced it has completed
- The Global Fund Names MS&L Its Global Communications and Media Relations Partner
- Business Wire - November 18, 2008
- NEW YORK & PARIS--The Global Fund, a public/private partnership dedicated to attracting and disbursing resources to prevent and treat HIV/AIDS, tuberculosis and malaria, has chosen MS&L, one of the world s leading global communications firms, to be its communications and media relations partner. The account wil
- Allion Healthcare Announces Partnership with Under One Roof to Service Patients in San Francisco
- Business Wire - November 18, 2008
- -- Under One Roof Sponsors 28 ASOs Reaching over 10,000 Patients Living with HIV/AIDS MELVILLE, N.Y.--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it has entered into a partnership with Under One Roof to launch a Community Resource Center in San Francisco. The build-out of the new center begins this wee
- Flowers Heritage Foundation "Bridge-the-Gap" Funding Goes to State of Montana for Second Consecutive Year
- Business Wire - November 18, 2008
- -- Funding to Minimize Impact on Montana s AIDS Drug Assistance Program OAKLAND, Calif.--The Flowers Heritage Foundation announced today that this year s Bridge-the-Gap recipient is the State of Montana AIDS Drug Assistance Program (ADAP). The Bridge-the-Gap program disperses funding obtained through charitable donatio
- Aethlon Medical Releases Shareholder Letter
- Business Wire - November 18, 2008
- SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, In my September shareholder letter, I referenced that our organization was heading into a pivotal month as we anticipated initial Hepatitis-C (HCV
- AIDS Advocates Rally on November 20 to Welcome Barack Obama Administration
- Business Wire - November 18, 2008
- -- 1000 Activists Will Rally in Washington and March to the Barack Obama Transition Office WASHINGTON---As World AIDS Day approaches, one thousand people living with HIV, and allies including Global AIDS Alliance, from across the United States , will rally for healthcare. Info at www.100daystofightaids.org/endorsements
- High Growth Reported for the World Pharmaceuticals Market Brief
- Business Wire - November 18, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. World Pharmaceuticals Market Brief http://www.reportlinker.com/p097881/World-Pharmaceuticals-Market- Brief.html The global outlook series on Pharmaceuticals provides a co
- High School Art Competition Keeps Pressure on the Fight Against HIV/AIDS
- Business Wire - November 17, 2008
- -- Contest Winners and Participants to Be Honored at Award Reception and Exhibition During World AIDS Weekend OAKLAND, Calif.--The Flowers Heritage Foundation announced today that more than 11 high schools are participating in its third annual high school art competition, Don t Turn Your Back On AIDS , to raise awarene
- Medical Anthropology: A Valuable Resource for Scholars and Students of Medical Anthropology and Health Professionals Alike
- Business Wire - November 17, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/b43df6/medical_anthro polo) has announced the addition of the Medical Anthropology report to their offering. This important volume includes key papers which outline the history, concepts, research findings and recent controversies in medi
- Nepal: AHF & National Center for HIV/AIDS, STI Control (NCASC) Dedicate Free AIDS Treatment 'Center of Excellence' in Kathmandu
- Business Wire - November 15, 2008
- -- Collaborative Antiretroviral Treatment Dedicated in Formal Ceremony Earlier this Week KATHMANDU, Nepal--Earlier this week, AIDS Healthcare Foundation (AHF), the largest AIDS group in the US, and Nepal s Ministry of Health, National Center for AIDS and STI Control (NCASC) dedicated a new Center of Excellence -a free
- American Red Cross of Greater Cleveland Honors 10 Community Heroes; Awards 2008 Community Leader Award to Dr. Delos “Toby” Cosgrove
- Business Wire - November 14, 2008
- CLEVELAND--(BUSINESS WIRE)--The American Red Cross of Greater Cleveland today honored 10 community heroes for acts of courage and compassion to others. In addition, Dr. Delos “Toby” Cosgrove, president and CEO of Cleveland Clinic, was awarded the organization’s Community Leader Award for his humanitarian work on behalf
- Project HOPE Celebrates 50 Years of Improving Health around the World
- Business Wire - November 14, 2008
- * Marks golden anniversary with weekend of festivities attended by representatives from three presidential families, foreign ambassadors and diplomats and other luminaries * HOPE sets sights on addressing three key global health challenges as it enters its next half century and celebrates five milestones from the last
- Genetic Immunity(R) Announces First Patient Dosed In Phase II Trial With DermaVir Patch For HIV Disease
- Business Wire - November 13, 2008
- MCLEAN, Va. & BUDAPEST, Hungary--(BUSINESS WIRE)--Genetic Immunity, a US/Hungarian clinical-stage company focused on development of nanomedicines for targeted immune amplification, today announced it has treated the first subject in a Phase II clinical study to evaluate DermaVir Patch. DermaVir Patch, the Company’s
- Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results
- Business Wire - November 13, 2008
- SAN DIEGO--(BUSINESS WIRE)--Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cancer and inflammatory diseases, today reported on recent accomplishments and financial resu
- Ardea Biosciences Secures $8 Million Growth Capital Loan
- Business Wire - November 13, 2008
- SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that it entered into an $8.0 million growth capital loan agreement with Oxford Finance Corporation and Silicon Valley Bank. Among its terms, the loan bears interest at 12% per annum over an approximate 3 year period and contains no financial covenants. In
- Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences
- Business Wire - November 13, 2008
- * ATC provided significant and durable antiviral activity over the 48-week treatment period, with a favorable safety profile and no evidence of resistance development * Antibacterial program shows activity particularly against drug-resistant Staphylococcus pathogens Ninth International Congress on Drug Therapy in HIV I
- Get a Deep Insight into the Vaccine Technologies and Global Markets
- Business Wire - November 13, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Vaccine Technologies and Global Markets http://www.reportlinker.com/p096550/Vaccine-Technologies-and- Global-Markets.html (Due to its length, this URL may need to be copi
- Learn about the Global Pharmaceutical Markets
- Business Wire - November 13, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Global Pharmaceutical Markets http://www.reportlinker.com/p096616/Global-Pharmaceutical-Markets .html (Due to its length, this URL may need to be copied/pasted into your
- Examine the DNA Diagnostics: Technologies and Global Markets
- Business Wire - November 13, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. DNA Diagnostics: Technologies and Global Markets http://www.reportlinker.com/p096610/DNA-Diagnostics-Technologies -and-Global-Markets.html (Due to its length, this URL may need t
- High Growth Reported for the Blood Industry
- Business Wire - November 13, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceu industry is available in its catalogue. The Blood Industry http://www.reportlinker.com/p096627/The-Blood-Industry.html The goal of this study on the blood industry is to describe and analyze the current markets for blood pro
- HIV Testing for Global 'One Million Tests' Campaign Begins During Cambodia's National Water Festival
- Business Wire - November 12, 2008
- -- AHF Cambodia CARES Donates 20,000 Kits to Government Testing Programs and Commits to Test 10,000 Individuals; Hard-hit Country Will Test 30,000 People Throughout November PHNOM PENH, Cambodia--As part of an ambitious global effort to test one million people for HIV in observance of the One Million Tests World AIDS D
- Top Serious Health Concerns for African Americans
- Business Wire - November 12, 2008
- -- A Few Preventive Tips Can Lower Risks for Life-Threatening Diseases and Chronic Debilitating Illnesses BOCA RATON, Fla.--The top serious health concerns for African Americans are: * Cardiovascular Disease-The #1 killer of African Americans. * Diabetes-3.2 million African Americans have diabetes, yet more than 33% do
- New York City's Mayor Bloomberg and Other Honorees Herald the Opening of the Only Laboratory Devoted Solely to AIDS Vaccine Design and Development
- Business Wire - November 12, 2008
- -- The International AIDS Vaccine Initiative Opens State-of-the-Art Laboratory in Planned New Bioscience Center in New York City NEW YORK--Today New York City Mayor Michael R. Bloomberg honored the International AIDS Vaccine Initiative (IAVI) at a ribbon-cutting ceremony for its new AIDS Vaccine Design and Development
- New York City Celebrates Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine
- Business Wire - November 12, 2008
- -- The International Aids Vaccine Initiative Opens State-of-the-Art AIDS Vaccine Lab at Historic Brooklyn Army Terminal The International AIDS Vaccine Initiative (IAVI) WHAT: The International AIDS Vaccine Initiative (IAVI) opens an AIDS Vaccine Design and Development Laboratory in New York City, the only facility in t
- Bold New Dell (PRODUCT)RED(TM) Artwork for Studio Laptops Express Passion for Art, Desire to Make a Difference
- Business Wire - November 11, 2008
- * Dell Expands the Palette of Its Art House Series with Three Exclusive (PRODUCT)RED Designs * Dell Spotlights (RED)-Inspired Artists and Their Visions in Global Gallery on Dell.com * For Each Dell (PRODUCT)RED Design Purchased, Dell Will Contribute $20 to the Global Fund, Helping to Save Lives and Eliminate AIDS in Af
- Palin's Favorite Store, Alaska's 'Out of the Closet' to Change Name by Year's End
- Business Wire - November 10, 2008
- -- Alaska Consignment Store Will Honor AIDS Healthcare Foundation s Federally Registered Out of the Closet Trademark for its Fundraising Non-profit Thrift Stores -- AHF Renews Call on RNC to Donate Governor s Campaign Wardrobe to AHF s Out of the Closet Chain; Since 1990, US Largest AIDS Group Has Run Popular and Award
- CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV
- Business Wire - November 10, 2008
- -- Leading R&D Company Will Continue Research for Both Therapeutic and Preventative Vaccines of Chronic Viral Diseases CORRECTION...by Profectus BioSciences, Inc. BALTIMORE--Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010). The corrected release reads: PROFECTUS BIOSCIENCES EXECUTES AN ASS
- ViroStatics' Chief Development Officer, Dr. Michael Stevens, to Present During Rodman & Renshaw's Tenth Annual Global Healthcare Conference on November 12, 2008
- Business Wire - November 10, 2008
- -- Rodman & Renshaw Annual Global Investment Conference SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced Chief Development Officer Dr. Michael Stevens will present a Company overview during Rodman & Renshaw s Tenth Annual Global Healthcare Conference taking place November 10 through 12, 20
- New York City Mayor Bloomberg and Other Honorees Celebrate Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine
- Business Wire - November 10, 2008
- -- The International AIDS Vaccine Initiative Opens State-of-the-Art AIDS Vaccine Lab at Historic Brooklyn Army Terminal --The International AIDS Vaccine Initiative WHAT: The International AIDS Vaccine Initiative (IAVI) opens a Vaccine Design and Development Laboratory in New York City, the only facility in the world ex
- Geron Scientists and Collaborators Demonstrate TAT2 - A Small Molecule Telomerase Activator - Enhances Antiviral Function of Immune Cells From HIV+ Donors
- Business Wire - November 10, 2008
- -- First Demonstration of Pharmacologic Approach to Enhance Immune Function Against Chronic Viral Infection via Telomerase Activation MENLO PARK, Calif.--Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data on TAT2, a small molecule telomerase activator. The studies show that human CD8+ T
- Inhibitex Reports Third Quarter 2008 Financial Results and Highlights
- Business Wire - November 7, 2008
- ATLANTA--Inhibitex, Inc. (NASDAQ: INHX) today announced its financial results for the third quarter ended September 30, 2008. We continued to perform in line with our near-term operational and financial goals during the third quarter, stated Russell H. Plumb, President and Chief Executive Officer of Inhibitex, Inc. We
- Allion Healthcare Reports Third Quarter 2008 Results
- Business Wire - November 6, 2008
- MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced financial results for the three months ended September 30, 2008, which include its recent expansion into the Specialty Infusion market. As a result of the April 4, 2008 acquisition of Biomed America, Inc. ( Biomed ), the Company now operates its business
- OraSure Technologies Announces 2008 Third Quarter Results
- Business Wire - November 5, 2008
- BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $16.9 million for the three months ended September 30, 2008, compared to $21.4 million in revenues for the three months ended September 30, 2007. Sales of the Company s OraQuick ADV
- Panacos Reports Third Quarter 2008 Financial Results
- Business Wire - November 5, 2008
- WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced its financial results for the third quarter of 2008 and reviewed progress in its development programs. We continue to make progress in ou
- OraSure Technologies to Sell OraQuick ADVANCE Rapid HIV-1/2 Antibody Test Directly to U.S. Hospitals
- Business Wire - November 5, 2008
- - OraSure Sales Force Expansion will Support Hospital Customers - BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that it will begin to sell its OraQuick ADVANCE(R) Rapid HIV-1/2 Antibody Test directly into the U.S. hospital market beginning in 2009.
- New York City Celebrates Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine: The International Aids Vaccine Initiative Opens State-of-the-Art AIDS Vaccine Lab at Historic Brooklyn Army Terminal
- Business Wire - November 5, 2008
- --The International AIDS Vaccine Initiative (IAVI) WHAT: The International AIDS Vaccine Initiative (IAVI) opens an AIDS Vaccine Design and Development Laboratory in New York City, the only facility in the world exclusively devoted to the development of an AIDS vaccine. IAVI will be the first occupant of a biotechnology
- AHF to President Barack Obama: AIDS Is a Crisis in America - US' Largest AIDS Group Calls on Government to Spend $200M for 10 Million HIV Tests
- Business Wire - November 04, 2008
- WASHINGTON -- AIDS Healthcare Foundation (AHF) (http://www.aidshealth.org), the largest non-profit HIV/AIDS organization in the US which currently provides medical care and services to more than 85,000 individuals in 22 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, today commended President-e
- NDRI Awarded $7.6 Million Grant From NIH For the Next Five Years to Fund Core Initiatives
- Business Wire - November 4, 2008
- PHILADELPHIA -- NDRI, the National Disease Research Interchange, announced that the National Institutes of Health (NIH) has awarded a $7.6 million grant to NDRI to enable the human tissue science organization to expand its core mission to collect, process, and distribute donated human tissue to hundreds of leading rese
- Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial - New Avenues for Vaccine Research
- Business Wire - November 3, 2008
- LAUSANNE, Switzerland & MONTPELLIER, France -- A study published today online in The Journal of Experimental Medicine sheds light on the potential mechanisms responsible for the increased incidence of HIV infection that was observed in the failed STEP HIV vaccine trial in 2007. Through the development of an experim
- New Data Suggest Long-Term Treatment with BARACLUDE(R) (entecavir) May Reduce Liver Damage Caused by Chronic Hepatitis B
- Business Wire - November 2, 2008
- Long-term cohorts evaluated for liver histology, including fibrosis, and viral load reduction SAN FRANCISCO -- Bristol-Myers Squibb Company (NYSE:BMY) today announced data from two separate cohort evaluations, in which long-term treatment with BARACLUDE(R) (entecavir) was associated with improved liver histology, inclu
- Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B - No Resistance Observed Through Two Years of Treatment - Significant Viral Suppression Seen in Patients Switching to Viread
- Business Wire - November 1, 2008
- SAN FRANCISCO -- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the presentation of two-year (96-week) data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread (R) ( tenofovir diso
- Argos Therapeutics to Discuss Personalized Dendritic Cell Immunotherapy Process at iSBTc Annual Meeting - Company to Provide Details on IL-12 as an Immunopotency Marker in a Poster Presentation
- Business Wire - October 31, 2008
- DURHAM, N.C. -- Argos Therapeutics today announced the presentation of details on the Company s dendritic cell-based immunotherapy process, Arcelis(TM), as well as new research into the potential of the cytokine IL-12 as an immunopotency marker. The Company s Arcelis(TM) technology is a proprietary platform for creatin
- Earvin "Magic" Johnson to Speak at First "Magic@50" Community Health EXPO
- Business Wire - October 30, 2008
- CHICAGO--Aetna (NYSE:AET) announced today that Earvin Magic Johnson will be the featured speaker at the first Magic@50 Community Health EXPO at the Harold Washington Cultural Center (4701 S. King Drive, Chicago, IL 60615) on Saturday, November 8th. This EXPO is free and open to the public, running from 10 a.m. to 2 p.m
- High Growth Forecasted for the Medical Diagnostic Kits
- BUSINESS WIRE - October 30, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. Medical Diagnostic Kits http://www.reportlinker.com/p096619/Medical-Diagnostic-Kits.html Describes the products that comprise the Medical Diagnostic Kits (MDK) industry Details e
- Examine the Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
- BUSINESS WIRE - October 30, 2008
- NEW YORK--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products http://www.reportlinker.com/p096699/Blood-The-Worldwide-Market- for-B
- Starbucks Joins (RED)TM to Help Save Lives in Africa
- Business Wire - October 29, 2008
- -- Partnership furthers Starbucks(TM) Shared Planet(TM) Commitment to the People and Communities that Grow Its Coffee SEATTLE and NEW ORLEANS--Starbucks Coffee Company (NASDAQ: SBUX) and (RED)(TM) today announced a multi-year partnership that will give coffee lovers a chance to do good every day. Through the partnershi
- Delivery and Expression of DNA and RNA, A Laboratory Manual to Gene Transfer
- BUSINESS WIRE - October 29, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/db3f79/gene_transfer_ del) has announced the addition of the Gene Transfer: Delivery and Expression of DNA and RNA, A Laboratory Manual report to their offering. Understanding gene function and regulation requires rigorous testing in live
- Ardea Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference and the Lazard Capital Markets 5th Annual Healthcare Conference
- BUSINESS WIRE - October 29, 2008
- SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer of Ardea Biosciences, will present at two upcoming investor conferences. Oppenheimer 19th Annual Healthcare Conference Date: Monday, November 3, 2008 Time: 1:20 p.m. Eastern Time Locat
- AHF'S AIDS Drug-Pricing Campaign Arrives in Abbott Executives' Home Mailboxes
- BUSINESS WIRE - October 29, 2008
- -- Shame on Abbott Postcard- Arriving in Mailboxes This Week- Targets Employees Neighborhoods Via Zip Codes Gleaned from Political Campaign Contribution Records --Direct Mail Piece Features Photo of CEO Miles D. White and Timeline of Abbott s Terrible Record on AIDS, Seeks to Raise Awareness About Co. s Abuse of NAFTA
- Revolutions Medical Corporation Files Pre Market 510K Application with the FDA for 3cc Rev Vac Safety Syringe
- Business Wire - October 28, 2008
- MOUNT PLEASANT, S.C.--Revolutions Medical Corporation (OTCBB: RMCP) today filed its 510k application with the Food and Drug Administration for its proprietary 3cc Rev Vac Safety Syringe. The Rev Vac safety syringe uses patented technology to draw the needle into the syringe chamber after use. This safety syringe should
- Cytheris Initiates Asian Phase I/IIa Clinical Trial of Interleukin-7 (IL-7) as an Immunotherapy in HCV Patients
- Business Wire - October 28, 2008
- -- Taiwan Trial Studies Patients Who Failed to Achieve SVR with Standard Treatment, and Complements Company s Two Other Investigations in Naïve and Previously Non-Responsive HCV Patients Currently Ongoing in Europe PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new
- Panacos Announces Preliminary Results of Bevirimat Study 204
- Business Wire - October 27, 2008
- -- Results confirm bevirimat tablet formulation dosed twice daily achieves target plasma levels WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) announced today the bevirimat Study 204 achieved its primary objective by demonstrating bevirimat plasma levels in HIV-positive patients to be in a target range
- Vertex Pharmaceuticals Highlights Progress with Hepatitis C and Cystic Fibrosis Programs and Reports Third Quarter 2008 Results
- Business Wire - October 27, 2008
- - Phase 3 ADVANCE study of telaprevir in HCV completes enrollment - Registration program for VX-770 in cystic fibrosis being discussed with global authorities- - As of September 30, 2008, Vertex had $920 million of cash, cash equivalents and marketable securities- CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (
- Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients
- Business Wire - October 27, 2008
- -- Results from MERIT ES Data Reanalysis Using Enhanced Sensitivity Tropism Test at 48 Weeks Patients taking Selzentry, in combination with Combivir (R) (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to screen patients, experienced a 68 percent rate of virologic suppression to undetectable
- Palin's Favorite Alaska 'Out of the Closet' Resale Store to Be Confronted over Trademark Issue by AIDS Healthcare Foundation - Press Teleconference, Mon. Oct 27th 8:00 a.m. Pacific
- Business Wire - October 27, 2008
- Since 1990s, US Largest AIDS Group Has Run Popular and Award Winning Fundraising Out of the Closet Thrift Store Chain in California and Florida under Registered Federal Trademark; AHF to Ask Governor Palin and RNC to Donate Candidate s Campaign Wardrobe to AHF s Out of the Closet Chain after Election LOS ANGELES -- AID
- Ardea Biosciences Presents Additional Phase 2a and Preclinical Data on its Lead HIV Product Candidate, RDEA806, at the 48th Annual ICAAC/IDSA 46th Annual Meeting: RDEA806 Moves into Phase 2b
- Business Wire - October 27, 2008
- SAN DIEGO -- Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that additional data from a Phase 2a monotherapy study of RDEA806, our lead non-nucleoside reverse transcriptase inhibitor (NNRTI) in development for the treatment of human immunodeficiency virus (HIV), were presented at the 48th Annual ICAAC/IDSA 46th
- Ardea Biosciences Presents Preliminary Data from a Phase 1 Study of RDEA594 at the 2008 ACR/ARHP Annual Scientific Meeting
- Business Wire - October 27, 2008
- SAN DIEGO -- Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that preliminary data were presented from an ongoing Phase 1 trial of RDEA594, its lead product candidate in development for the treatment of hyperuricemia and gout, at the 2008 American College of Rheumatology (ACR) / Association of Rheumatology Health
- New Phase III Study in Previously Untreated HIV Patients Showed Merck’s ISENTRESS(R) (raltegravir) Reduced HIV Viral Load to Undetectable Levels, Comparable to Efavirenz, When Taken in Combination with Other Medicines: Study Showed ISENTRESS Increased CD4 Cells More Than Efavirenz, with Significantly Fewer Side Effects
- Business Wire - October 26, 2008
- WASHINGTON -- In a new Phase III study that compared Merck & Co. , Inc. s HIV integrase inhibitor ISENTRESS(R) (raltegravir) to efavirenz [one of the leading antiretrovirals prescribed for previously untreated (treatment-naïve) HIV-infected patients], ISENTRESS reduced HIV viral load to undetectable levels (less th
- Panacos Presents Phase 2b Bevirimat Data at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
- Business Wire - October 26, 2008
- WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that data from the Company s Phase 2b study of bevirimat, Panacos lead HIV-1 Gag maturation inhibitor, was shown in an oral presentatio
- Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients: Results from MERIT ES Data Reanalysis Using Enhanced Sensitivity Tropism Test at 48 Weeks
- Business Wire - October 26, 2008
- NEW YORK -- Patients taking Selzentry, in combination with Combivir (R) (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to screen patients, experienced a 68 percent rate of virologic suppression to undetectable levels, according to the MERIT ES (Reanalysis of the MERIT Study with the Enhanc
- Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140: Both intravenous and subcutaneous forms of PRO 140 showed potent and prolonged activity and were generally well tolerated
- Business Wire - October 26, 2008
- WASHINGTON & TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced positive interim results from two separate phase 2 clinical trials of PRO 140 for the treatment of HIV infection. Both intravenous and subcutaneous forms of PRO 140, a novel viral-entry inhibitor, exhibited potent and pro
- 96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/Ritonavir and Twice-Daily Lopinavir/Ritonavir In Previously Untreated HIV-1 Infected Adult Patients: Data continue to show differences in gastrointestinal and lipid effects among study population
- Business Wire - October 26, 2008
- PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week data from the CASTLE study, in which 74 percent of the 440 patients in the REYATAZ(R) ( atazanavir sulfate)/r arm achieved an undetectable viral load, defined as HIV-1 RNA less than 50 copies/mL, compared with 68 percent of the 443 pati
- Tiny Prints Kicks Off a Season of Giving
- Business Wire - October 25, 2008
- MOUNTAIN VIEW, Calif. -- Tiny Prints Inc. (www.tinyprints.com), a leading online retailer of premium, personalized stationery, recently came together to offer their time for causes that matter to their workforce through outreach programs that support both the global and local community. This year, Tiny Prints is kickin
- Pop!Tech Unveils Project Masiluleke: Largest-Ever Use of Mobile Devices for Delivery of HIV/AIDS & TB Care
- Business Wire - October 24, 2008
- frog design, Praekelt Foundation, iTeach, National Geographic, Nokia Siemens Networks, MTN, and Others Align for Path-Breaking Social Innovation Program Project M Designed as Scalable and Replicable Solution to Public Health Crises in South Africa and Beyond CAMDEN, Maine & JOHANNESBURG, South Africa -- Pop!Tech (w
- CDC Advisory Panel Votes to Update Pneumococcal Vaccination Recommendations
- Business Wire - October 23, 2008
- -- Vote expands recommendation to include adults aged 19-64 who have asthma and those who smoke cigarettes WHITEHOUSE STATION, N.J.--The U.S. Centers for Disease Control and Prevention s (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously yesterday to recommend that adults ages 19 to 64 with ast
- Bristol-Myers Squibb Continues Excellent Financial Performance Led By Double-Digit Global Net Sales Growth and Strong Earnings Results
- Business Wire - October 23, 2008
- NEW YORK-- Bristol-Myers Squibb Company (NYSE:BMY): * Reports Broad-Based Net Sales Growth of 14% from Continuing Operations * Records Growth in GAAP Diluted EPS of $1.29 Compared to $0.43 in 2007; Includes After-Tax Gain of $0.99 Per Share From Sale of ConvaTec * Posts 2008 GAAP Diluted EPS from Continuing Operations
- Friday, Oct. 24th: Grand Opening of 'Out of the Closet' Thrift Store, Echo Park
- Business Wire - October 22, 2008
- -- Just in Time for Halloween, New Location of World s Most Fabulous Thrift Store Opens to the Public — Stocked with Everything Needed to Create a Unique Costume -- Proceeds Benefit Nonprofit AIDS Healthcare Foundation; Ninety-Six Cents of Every Dollar Earned Goes to the Care and Treatment of People Living with HIV/AID
- Saturday, Oct. 25: Peter Paige of "Queer as Folk" to Host "Out of the Closet's" Halloween Bash at Arena Hollywood
- Business Wire - October 22, 2008
- --Funds Raised Will Support AIDS Healthcare Foundation, a Nonprofit Provider of HIV/AIDS Testing, Treatment and Other Services LOS ANGELES--AIDS Healthcare Foundation: What: Out of the Closet s Halloween Bash at Arena Hollywood Benefiting AIDS Healthcare Foundation Featuring a silent auction, games, prizes, dancing and
- CytoDyn Files New IND For Cytolin(R)
- Business Wire - October 22, 2008
- SANTA FE, N.M.--CytoDyn, Inc. (Pink Sheets:CYDY) has filed a new IND for a study to reconfirm dose ranging and to prove the principle with a randomized, double-blind placebo controlled study of Cytolin(R), the Company s first-in-class drug for treating HIV/AIDS. This comes 13 years after the first IND was issued for th
- Allion Healthcare Announces Date of Third Quarter 2008 Financial Results and Conference Call
- Business Wire - October 22, 2008
- MELVILLE, N.Y.--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended September 30, 2008, after the close of U.S. financial markets on Thursday, November 6, 2008. An accompanying conference call to discuss the results will be held at 5:00 p.m. ET
- Merck Reports Third-Quarter 2008 Financial Results
- Business Wire - October 22, 2008
- * Company Announces Third-Quarter 2008 Non-GAAP EPS of $0.80, Excluding 29 Cents of Restructuring Charges; Third-Quarter GAAP EPS of $0.51 * 2008 Global Restructuring Efforts Expected to Reduce Workforce by 12 Percent; Cumulative Savings of $3.8 to $4.2 Billion Expected from 2008 to 2013 and Pretax Costs of $1.6 Billio
- Major Government Clinical Study Approved for Anadis' AIDS Therapy
- Business Wire - October 21, 2008
- NEW YORK & MELBOURNE, Australia--Anadis Ltd. (ANX.AX ; ANDIY.PK; CUSIP: 032517104) announced today that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research (NCHECR) and the University of New South Wales (UNSW), both in Sydney, that their Institutional Review Board has ap
- Viral Genetics, Inc. Releases Initial Findings of Lyme Disease Study
- Business Wire - October 21, 2008
- -- Team Receives Positive Feedback at ILADS Conference, Study Model Potentially Applies to HIV/AIDS and Other Immune Based Diseases SAN MARINO, Calif.--Viral Genetics, Inc. (OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled to the general public initial findings of it
- Department of Health and Human Services Awards ICF International Contract Valued at $4M
- Business Wire - October 21, 2008
- -- ICF International to Lead HIV/AIDS and STD Awareness and Prevention Program FAIRFAX, Va.--Z-Tech, a subsidiary of ICF International (NASDAQ:ICFI), announced today that it was awarded a new contract by the Department of Health and Human Services (HHS) to provide regionally based technical assistance and training for
- Google.org Battles Bugs & Viruses
- Business Wire - October 21, 2008
- -- Announces More Than $14 Million in Grants to Partners Working to Predict and Prevent the Next Pandemic MOUNTAIN VIEW, Calif.--Google.org, the philanthropic arm of Google (NASDAQ:GOOG), has announced grants of more than $14 million to support partners working in Southeast Asia and Africa to prevent the next pandemic.
- Trimeris Reports Third Quarter 2008 FUZEON(R) Sales Results
- Business Wire - October 20, 2008
- * Worldwide Net Sales up 19 Percent over the Second Quarter of 2008 * Worldwide Net Sales for the First Three Quarters of 2008, Down 37 Percent over the Same Period Last Year DURHAM, N.C.--Trimeris, Inc. (Nasdaq:TRMS) today announced worldwide net sales of FUZEON for the third quarter of 2008 were $45.5 million, down 3
- Aetna First Health Plan to Link Gay and Lesbian Medical Association Provider Directory to Its Own Online Doctor Resource
- Business Wire - October 20, 2008
- -- Company committed to increasing openness, quality of health care -- -- Sponsors the Gay and Lesbian Medical Association s 26th Annual Conference, world s largest gathering of lesbian, gay, bisexual and transgender health professionals -- SAN FRANCISCO--Aetna (NYSE:AET) and the Gay and Lesbian Medical Association (GL
- Ardea Biosciences Awarded Composition of Matter Patent Covering RDEA806, Its Lead NNRTI for the Treatment of HIV
- Business Wire - October 17, 2008
- SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that the United States Patent and Trademark Office has issued a patent covering the composition of matter of RDEA806, the Company s lead non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of patients with human immunodeficiency virus
- Sat., Oct 18th: 'AHF Pharmacy' to Open in Hollywood, Revenues Re-Invested in HIV/AIDS Care
- Business Wire - October 17, 2008
- -- New Location Opens This Saturday, October 18th Next to AHF s Popular Out of the Closet Thrift Store on Sunset Blvd. in Hollywood -- Recent TV Ad Features Actor Blair Underwood Encouraging Everyone to Fill Prescriptions at AHF Pharmacy; Ninety-six Cents of Every Dollar Earned Goes to Treating People Living with HIV/A
- Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor's TriGrid to be Presented at AIDS Conference: First-ever Clinical Trial Using Electroporation to Test Preventive HIV Vaccine
- Business Wire - October 17, 2008
- SAN DIEGO -- Ichor Medical Systems, whose advanced TriGrid(TM) Delivery System is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today that preliminary safety and tolerability data for a Phase I preventive HIV vaccine clinical trial being conducted at the Rockefeller Uni
- Ardea Biosciences Initiates a Phase 1/2 Study of RDEA119, its Lead MEK Inhibitor, in Combination with Nexavar(R) (sorafenib) in Patients with Advanced Cancer
- Business Wire - October 16, 2008
- SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that it has initiated a Phase 1/2 study of RDEA119, its lead mitogen-activated ERK kinase (MEK) inhibitor for the treatment of cancer, in combination with Nexavar, which is currently approved for the treatment of unresectable hepatocellular carcinoma and
- VGX Pharmaceuticals Presents Non-Human Primate Study Data at AIDS Vaccine 2008 Conference
- Business Wire - October 15, 2008
- BLUE BELL, Pa.--VGX Pharmaceuticals (VGXP), a developer of DNA vaccines against cancer and infectious diseases, presented today non-human primate study data from both its PENNVAX(TM) HIV Vaccine Program and its patented CELLECTRA(R) DNA Delivery technology in two presentations at the AIDS Vaccine 2008 Conference curren
- Finalists Selected For The BioWest 2008 Venture Showcase Competition
- Business Wire - October 15, 2008
- DENVER--New therapeutic drugs for life threatening disease and trauma; devices made of new materials that work with the body; a highly-sensitive detector of trace amounts of biological and chemical agents in real time; new DNA immunotherapies for HIV infection; high-protein, low-cost fish food; and, new materials for u
- The Burnham Buzz: Recent Developments at the Burnham Institute for Medical Research October 2008
- Business Wire - October 14, 2008
- LA JOLLA, Calif.--Burnham Institute for Medical Research announces recent developments. $98 Million Dollar Grant Supports Drug Discovery In a time of shrinking government funding, the Burnham Institute for Medical Research has received a record $98 million grant from the National Institutes of Health (NIH) to expand th
- Aethlon Medical Announces Completion of Human Safety Study
- Business Wire - October 14, 2008
- -- Reports Further Results of Hepatitis-C Patients Treated With the Aethlon Hemopurifier(R) SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced the completion of a human safety study conducted at the Fortis Hospital in Delhi, India . The primary objective of the study was to evaluate the safety of the Aethlon
- BioAlliance Pharma Was Informed That a Civil Action Was Filed by Eurofins in the United States
- Business Wire - October 14, 2008
- PARIS--Regulatory News: BioAlliance Pharma (Paris:BIO) was informed that a civil action was filed in Delaware by Eurofins Pharma US Holding Inc. and one of its affiliates Viralliance Inc. (Eurofins) against BioAlliance Pharma and one of its executives. The action concerns the use of intellectual property related to the
- OraSure Technologies Helps Expand Access to Rapid HIV Testing in Recognition of National Latino AIDS Awareness Day, October 15, 2008
- Business Wire - October 13, 2008
- -- Company Joins the Latino Commission on AIDS in Urging All Latinos to Get Tested and Learn Their HIV Status BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, announced today its support to expand access to rapid HIV testing in recognition of National Latino AIDS Aw
- Calypte Biomedical Corporation Receives Large Order for Aware Diagnostic Test from Middle Eastern Distributor
- Business Wire - October 13, 2008
- -- New Sales Initiative Beginning to Yield Results PORTLAND, Ore.--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that it has received an order for 50,000 tests of its Aware™ HIV-1/2 OMT product from LifeLine Scientific, its newly appointed
- Teen Sex Education Website Teensource.org Launches Official YouTube Channel
- Business Wire - October 13, 2008
- -- Teensource.org, a Website Dedicated to Teen Sexual Health, Has Launched an Official YouTube Channel at http://www.youtube.com/teensource; The Teensource.org YouTube Channel Debuts Today with Educational Videos about Teen Sex Education, and Sexual Health LOS ANGELES--Teensource.org, a sexual education website that fo
- HIV Commercial Insight: The Battle for the $9.3 Billion Market Share is Getting Fiercer
- Business Wire - October 10, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/b776d8/commercial_insight) has announced the addition of the Commercial Insight: HIV - The Battle for Market Share is Getting Fiercer report to their offering. In 2007, HIV drugs achieved sales of $9.3 billion in the 7MM, growing faster t
- ROTATEQ(R) Receives WHO Pre-qualification
- Business Wire - October 10, 2008
- --Significant Step in Merck s Efforts to Expand Global Access to Rotavirus Vaccine WHITEHOUSE STATION, N.J.--ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent), the pentavalent rotavirus vaccine from Merck & Co. , Inc., that helps prevent rotavirus gastroenteritis in infants and children, has been awarded pre-
- Florida: Orange County Nixes Public Comment on Tainted AIDS Pharmacy Bid Process at Commissioners' Meeting, Notes AHF
- Business Wire - October 8, 2008
- -- County Official Pre-empts Public Comment by Non-profit AIDS Service Provider on Disputed AIDS Pharmacy Services Contract Saying it Would Not Be Inappropriate -AHF Asserts County s Bid Process Violated Federal Regulations Under Ryan White CARE Act ORLANDO, Fla.--AIDS Healthcare Foundation (AHF), the nation s largest
- Viral Genetics, Inc. Invited to Present New Model, Initial Findings of Lyme Disease Study at Prestigious ILADS Conference
- Business Wire - October 8, 2008
- -- Study Group Beginning Further Research, Which it Hopes Will Unlock Mysteries, Reconcile Debate Over Lyme Treatment, Offer Answers to Other Immune Based Diseases AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today announced it has bee
- Panacos' Study 114 Supports the Company's New Tablet Formulation of Bevirimat
- Business Wire - October 7, 2008
- -- 100mg Tablet Formulation will Move Forward in Development -- WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (Nasdaq: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced its 100mg tablet formulation of bevirimat has shown very good bioavailabi
- CytoDyn Relocates Offices to Accommodate Expanded Activities
- Business Wire - October 7, 2008
- SANTA FE, N.M.--CytoDyn, Inc. (Pink Sheets:CYDY) has relocated its business offices to 1511 Third Street, Santa Fe, NM 87505. The Company s new phone number is 505-412-6480. The FAX number remains the same: 800-417-7252. The expanded office space will accommodate the staff needed to bring CytoDyn s periodic filings up
- Florida: Orange County Sued Over Tainted AIDS Pharmacy Bid Process by AHF
- Business Wire - October 6, 2008
- -- Non-profit AIDS Service Provider Says Orange County Officials Violated Federal Regulations and Committed Repeated Illegal Acts; Group Claims County Places Bureaucracy Above Patient Needs ORLANDO, Fla.--AIDS Healthcare Foundation: WHAT: Press Conference--Filing of LEGAL COMPLAINT by AHF Pharmacy Against Orange County
- BioAlliance Acts in Favour of Patients' Quality of Life in Connection with the French National Event 'La Semaine du Gout'
- Business Wire - October 6, 2008
- PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, announced its collaboration to the book entitled Rediscover the pleasure of food , containing culinary recommendations and recipes targeted at cancer p
- Macy's Celebrates Milestone 150th Birthday on October 28, 2008
- Business Wire - October 6, 2008
- -- Month-Long Celebration Includes National Rollout of Signature Fashion Show, New Orleans Store Openings, a Customer Shopping Event and a Fashion Industry Gala NEW YORK--Macy s (NYSE:M) is celebrating an epic milestone this month as the famous retailer marks its 150th birthday on October 28. A local retail store turne
- AHF Steps Up "Shame on Abbott" Advocacy Campaign in Abbott Park, IL
- Business Wire - October 6, 2008
- -- Print Ad-which Appeared in Saturday s Lake County News-Sun-Focuses on Abbott CEO Miles D. White and His Company s Terrible Record on AIDS -- Campaign Highlights Abbott s Latest Shameful Act: Exploiting NAFTA to Charge Five Times More for Its Key AIDS Drug Kaletra in Mexico
- Avexa Bolsters Board of Directors and Appoints New Chairman
- Business Wire - October 6, 2008
- MELBOURNE, Australia--Avexa Limited (ASX:AVX) today announced that Nathan Drona will replace Stephen Cooper as Chairman of the Board while David Bottomley and Alan Boyd represent new additions to the Board. Mr. Cooper, who was serving as interim Chairman, will be stepping down from the Board to focus on his activities
- NanoViricides, Inc. to File Annual Report Shortly; Discusses Status of Current Projects
- Business Wire - October 6, 2008
- -- Temporary Stock Symbol Change Will Be Reversed WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), commented on the recent and temporary change of its quotation symbol from NNVC.OB to NNVCE.OB. The E reflects that the Company has not yet filed its Form 10-KSB, annual report to shareholders. The
- Examine Thailand's Pharmaceuticals and Healthcare Industry with this Comprehensive Report Q3 2008
- Business Wire - October 3, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/32f8ba/thailand_pharm aceu) has announced the addition of the Thailand Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. BMI s Thailand Pharmaceuticals and Healthcare Report provides independent forecasts and competi
- Examine Zimbabwe's Pharmaceuticals and Healthcare Industry with this Comprehensive Report, Q3 2008
- Business Wire - October 3, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/867691/zimbabwe_pharm aceu) has announced the addition of the Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. BMI s Zimbabwe Pharmaceuticals and Healthcare Report provides independent forecasts and competi
- Standard & Poor's Initiates Factual Stock Report Coverage on Mymetics Corporation
- Business Wire - October 2, 2008
- NEW YORK--Standard & Poor s announced today that it has commenced Factual Stock Report coverage on Mymetics Corporation. Mymetics Corporation (OTCBB:MYMX), is a biotechnology company focused on developing prophylactic vaccines, presently focusing on vaccines against the human immunodeficiency virus (HIV/AIDS) and m
- Progenics Announces Progress and Presentations in HIV Therapy Program
- Business Wire - October 2, 2008
- -- Enrollment for PRO 140 phase 2 clinical studies completed -- -- Interim phase 2 results for intravenous form of PRO 140 to be presented at late-breaker ICAAC session -- -- PRO 140 phase 1b clinical study results published in Journal of Infectious Diseases -- TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (Nasdaq:
- GenVec Receives Third-Year Funding from NIAID for HIV Vaccine Contract
- Business Wire - October 2, 2008
- GAITHERSBURG, Md.--GenVec, Inc. (Nasdaq:GNVC) announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its second option period (year three) under a previously announced, five-year contract with GenVec valued at up to $52 millio
- U.S. Food & Drug Administration Approved the use of REYATAZ(R) (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- Business Wire - October 1, 2008
- PRINCETON, N.J.-- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food & Drug Administration ( FDA ) approved the use of REYATAZ(R) ( atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as par
- VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation: U.S. Government Grant Supports Preclinical and Clinical Development, Manufacturing and Other Activities for VGX's HIV DNA Vaccine Candidate
- Business Wire - October 1, 2008
- BLUE BELL, Pa.--VGX Pharmaceuticals (VGX), a developer of DNA vaccines against cancer and infectious diseases that has entered into a definitive merger agreement with Inovio Biomedical (AMEX:INO - News), announced today that the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National
- Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets (Ehrlich II) in Nürnberg, Germany
- Business Wire - October 1, 2008
- SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced the Company s President and CEO, Dr. Franco Lori, will be speaking at the prestigious 2nd World Conference on Magic Bullets (Ehrlich II) in Nürnberg, Germany on Saturday, October 4th 2008. Dr. Lori will address the international conference on the su
- AHF Applauds Schwarzenegger for Signing First-in-the-Nation HIV Testing Coverage Bill
- Business Wire - September 30, 2008
- -- AB 1894 (Krekorian, D-Burbank), Sponsored by AHF, Compels Insurers Operating in California to Cover Costs of Routine HIV Tests -- Legislation Will Help California Comply with CDC s Updated 2006 HIV Testing Guidelines Recommending Routine HIV Screening for All Individuals Ages 13 to 65 --(BUSINESS WIRE)--AIDS Healthc
- Incyte to Present at JMP Securities Third Annual Healthcare Focus Conference
- Business Wire - September 30, 2008
- WILMINGTON, Del.--Incyte Corporation (Nasdaq:INCY) announced today it will present at the JMP Securities Third Annual Healthcare Focus Conference on Monday, October 6, 2008 at 11:00 a.m. (Eastern Time). Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and dis
- Allion Healthcare to Present at Maxim Group Growth Conference
- Business Wire - September 30, 2008
- MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Maxim Group Growth Conference at 8:30 a.m. (Eastern) on Tuesday, October 7, 2008 at the Grand Hyatt Hotel in New York, New York. Mike Moran, Allion s Chairman, President and Chief Executive Officer and Russ Fichera, Chief Finan
- Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development
- Business Wire - September 30, 2008
- SEATTLE--Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company s Scientific Advisory Board and Jeff Parkins has been promoted to Vice President, Clinical Development. Dr. Fletcher was appointe
- OraSure Applauds Congress for Passing Legislation to Enable Routine HIV Testing Throughout the U.S. Veterans Health Care System
- Business Wire - September 29, 2008
- BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today issued a statement applauding the U.S. Congress for passage of The Veterans Mental Health and Other Care Improvements Act of 2008 (S. 2162). The bill includes a provision that repeals the 1988 Veterans Benefits
- Aethlon Medical Initiates First Clinical Study Of a Medical Device to Treat HIV/AIDS Patients
- Business Wire - September 29, 2008
- SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has initiated patient enrollment in the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). The device, known as the Aethlon Hemopurifier
- Schwarzenegger Signs Crucial California HIV Testing Bill: Targeting Repeat Testers (AB 2899, Portantino, D-Pasadena)
- Business Wire - September 29, 2008
- -- Bill Streamlines HIV Counseling and Education Services for People Who Have Previously Tested and Received Such Counseling and Preventive Education Before SACRAMENTO, Calif.--AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised Governor Arnold S
- Q3 2008 Report for the Indonesia Pharmaceuticals and Healthcare Industry
- Business Wire - September 28, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/16dd16/indonesia-pharmace) has announced the addition of the Indonesia Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. Indonesia has a rapidly growing population of 240 million and has witnessed many of its neighbo
- AHF Advocacy Spurs GSK to Suspend Fear-Mongering AIDS Drug Ads
- Business Wire - September 26, 2008
- -- AHF Runs Pieces Headlined GSK: Worst Drug Ads Ever. The Issue Prompts Articles in the Wall Street Journal and Philadelphia Inquirer; Subsequently, Company Pulls Ads -- AHF and Others Believe Controversial Ad Campaign Was an Attempt by GSK to Maintain Market Share, to Detriment of Patient Health LOS ANGELES--AIDS Hea
- An Industry Analysis of the Anti-Infectives Market Outlook to 2013: Examine the Competitive Landscape, a Pipeline Analysis & Growth Opportunities
- Business Wire - September 26, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/a7d0e3/the_antiinfect ive) has announced the addition of the The Anti-Infectives Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities report to their offering. The market for anti-infectives related di
- ISENTRESS(TM) (raltegravir) Awarded Prix Galien USA Top Honor
- Business Wire - September 25, 2008
- WHITEHOUSE STATION, N.J.--ISENTRESS(TM) (raltegravir), Merck s medicine for HIV/AIDS, received the Prix Galien USA 2008 Award for Best Pharmaceutical Agent, Merck & Co. , Inc. announced today. We are delighted that more than a decade of work by Merck researchers has been recognized with such a prestigious award, s
- AHF Urges Passage of 'Stop AIDS in Prison Act': As H.R. 1943 (Waters, D-CA) Goes Before Senate Judiciary Committee Today, Nation's Largest AIDS Organization Calls Bill "Urgent Lifesaving Legislation"
- Business Wire - September 25, 2008
- WASHINGTON -- AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which currently provides treatment, care and support services to more than 80,000 individuals in 22 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, urges the passage of the Stop AIDS in
- Telaprevir Presentations at the 59th AASLD Meeting to Feature SVR Data in Treatment-Naive and Treatment-Failure Genotype 1 HCV Patients, and Clinical Data Exploring Twice-Daily Dosing Regimens
- Business Wire - September 24, 2008
- CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that key data on sustained viral response (SVR) rates in both treatment-naive and treatment-failure genotype 1 hepatitis C (HCV) patients who received telaprevir-based treatment regimens will be presented at the 59th Annual Meeting of
- AHF Calls on Iran to Release Two Respected AIDS Physicians Held Since June
- Business Wire - September 23, 2008
- -- Dr. Kamiar Alaei and Dr. Arash Alaei-Two Brothers Internationally Known for their Work on HIV/AIDS-Have Been Detained Without Charge By Iranian Officials Since June 2008 -- US Largest AIDS Group Joins International Call to Press Iranian President Mahmoud Ahmadinejad, Who is to Speak Today at the UN General Assembly
- Use of AIDS Test Can Prolong Life While Saving Money, Stanford Study Finds
- Business Wire - September 22, 2008
- STANFORD, Calif.--A simple test given to HIV/AIDS patients in southern Africa could extend their lives by nearly a year and save health-care costs at the same time, according to a new study by researchers at the Stanford University School of Medicine and the Palo Alto Veterans Affairs Health Care System. The technique,
- UCSF Celebrates 45th Anniversary of Transplant Service
- Business Wire - September 19, 2008
- SAN FRANCISCO--As a world leader in organ transplantation, UCSF will celebrate its 45th year of transplantation with a week of exciting workshops, lectures and forums. Virtually every single person in this country knows someone who has end-stage organ disease and who could benefit from transplantation, said Nancy Asche
- No-Fee Quick Collect Money Transfer Services to Benefit Humanitarian Relief Organization in Haiti: Public May Donate to CARE Through Western Union No-Fee Service
- Business Wire - September 19, 2008
- SUNRISE, Fla.--Western Union, a leading provider of global money-transfer services, announced today it has established a Quick Collect account that will allow the public in the U.S. to donate to CARE for disaster relief efforts currently underway in Haiti . Individuals and corporations wishing to donate to disaster rel
- This Essential German Pharmaceuticals and Healthcare Report is Available Now
- Business Wire - September 19, 2008
- DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/6766fb/germany_pharma ceut) has announced the addition of the Germany Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. Our Germany Pharmaceuticals and Healthcare Report provides independent forecasts and competitive
- OraSure Technologies to Participate at the 2008 UBS Global Life Sciences Conference
- Business Wire - September 18, 2008
- BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the 2008 UBS Global Life Sciences Conference in New York City at approximately 2:30pm Eastern Time, (11:30am Pacific Time) on Tuesday, Septem
- Press Conference to Announce September 18, 2008 as the Launch of the First Annual National HIV/AIDS and Aging Awareness Day
- Business Wire - September 18, 2008
- FT. LAUDERDALE, Fla.--September 18, 2008 marks the launch of a new national awareness initiative of The AIDS Institute entitled National HIV/AIDS and Aging Awareness Day (NHAAAD). This national campaign will highlight the complex issues related to HIV prevention, care and treatment for aging populations in the
- Kenneth Cole To Receive Humanitarian Designer Award at Islands of the World Fashion Week
- Business Wire - September 17, 2008
- NASSAU, Bahamas--Owen Bethel, President of Mode Iles, Ltd., founder and organizer of Islands of the World Fashion Week, announced today that the Humanitarian Designer Award will be presented to Kenneth Cole and Kenneth Cole Productions, Inc. during Islands of the World Fashion Week in November, 2008. Mr. Bethel stated
- Aethlon Medical Reports Promising Treatment Results In Hepatitis-C Infected Patients
- Business Wire - September 17, 2008
- SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced preliminary data of Hepatitis-C (HCV) infected patients treated with the Aethlon Hemopurifier(R), a medical device designed to assist the immune response in combating infectious disease. The HCV treated patients were among end-stage renal disease (kidney di
- 'Shame on Abbott': AIDS Healthcare Foundation's New Ad: Campaign Blasts Drug Company for Exploiting NAFTA to Charge Five Times More for Its Key AIDS Drug Kaletra in Mexico Than in Other Middle-Income Countries
- Business Wire - September 16, 2008
- LOS ANGELES--As part of its ongoing campaign to lower drug prices and improve access to lifesaving AIDS treatments globally, AIDS Healthcare Foundation (AHF), which operates three free treatment clinics in Mexico (Puerto Vallarta, Cancun and Tuxtla Gutierrez) today unveiled a new print advertisement criticizing
- BioAlliance Pharma Announces Participation in the MidCap Event on September 29 and 30, 2008
- Business Wire - September 16, 2008
- -- MidCap Event PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris: FR0010095596-BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced that it will participate in the MidCap Event, a forum dedicated to meetings between i
- Remarks by President Bush and President Kufuor of Ghana in Joint Statement
- Business Wire - September 15, 2008
- WASHINGTON--Rose Garden 11:00 A.M. EDT PRESIDENT BUSH: Good morning. I m pleased to be here with my friend, the President of Ghana , John Kufuor of Ghana. We just had a very good discussion and before I summarize it I do want to say a word about the U.S. economy. I know Americans are concerned about the adjustments tha
- Experts Call on Governor Schwarzenegger to Sign AB 1894 to Prevent the Spread of HIV/AIDS: California Poised to Lead the Nation in Setting Medical Standard in HIV/AIDS Prevention
- Business Wire - September 11, 2008
- SACRAMENTO, Calif.--Today, California s leading HIV/AIDS and healthcare experts called on the Governor to sign AB 1894 (authored by Assembly Member Paul Krekorian) in light of new data from the Centers for Disease Control and Prevention (CDC). This August, the CDC announced that the United States has been under-est
- BioScrip and United Healthcare to Exit Specialty Services Agreement in 2009
- Business Wire - September 11, 2008
- -- Financial Impact Estimated at $2.0 Million for 2009 ELMSFORD, N.Y.--BioScrip, Inc. (Nasdaq: BIOS) announced today that UnitedHealthcare, a UnitedHealth Group (NYSE: UHG) company, has notified the Company of its intention to internalize services for HIV/AIDS and Solid Organ Transplant drugs for United members effecti
- New Study Building off Viral Genetics' Research Aims to Unlock the Mysteries behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS
- Business Wire - September 10, 2008
- -- Gift from Undisclosed Source Will Go towards Study Which Researchers Hope Will Reconcile Long-Standing Debate over Treatment of Lyme Disease AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, announced today it has completed an initial st
- Thousands of Children Benefit from the Association of Hole in the Wall Camps
- Business Wire - September 10, 2008
- NEW HAVEN, Conn.--The Association of Hole in the Wall Camps had another successful camp season, largely exceeding the number of children who attended camp last year. This summer, five camps in the United States and five camps in Europe, as well as programs in Africa and Southeast Asia, provided opportunities for childr
- Argos Therapeutics Initiates Phase 2 Trial in Renal Cell Carcinoma for its Arcelis(TM) Personalized Immunotherapy Platform
- Business Wire - September 10, 2008
- -- AGS-003 to be tested in combination with sunitinib DURHAM, N.C.--Argos Therapeutics today announced the initiation of a Phase 2a trial of its AGS-003 therapy, in combination with sunitinib, for the treatment of newly diagnosed advanced renal cell carcinoma (RCC). AGS-003 is a product of the Company s Arcelis(TM) tec
- Altor BioScience Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital
- Business Wire - September 10, 2008
- MIRAMAR, Fla.--Altor BioScience Corporation (Altor) today announced that it has entered into an agreement with Massachusetts General Hospital (MGH) for exclusive, worldwide rights to develop and commercialize T-cell receptors (TCRs) specific for cells infected by HIV and Hepatitis C Virus (HCV). The license has resulte
- American Express Announces Top 25 Projects Competing for $2.5 Million in Funding Through Members Project(R)
- Business Wire - September 9, 2008
- -- Cardmember Vote Will Determine Which Projects Advance to Top Five NEW YORK--American Express unveiled today the top 25 projects selected as semi-finalists for Members Project (www.membersproject.com), the online initiative that invites Cardmembers to come together to submit, discuss and vote for projects to make a p
- The Tech Museum of Innovation Announces 2008 Tech Awards Laureates
- Business Wire - September 9, 2008
- -- Twenty-Five Innovators From Around the World Recognized for Developing and Applying Technology to Benefit Humanity SAN JOSE, Calif.--The Tech Awards, presented by Applied Materials (Nasdaq:AMAT), and a signature program of The Tech Museum of Innovation, today announced the 2008 Tech Awards Laureates, 25 global innov
- Remarks by the First Lady at a "ONE" Campaign Event
- Business Wire - September 4, 2008
- MINNEAPOLIS--Minneapolis Convention Center 3:06 P.M. CDT MRS. BUSH: Thank you very much, Cindy. Thanks a lot. Thank you all. Thanks to everybody who s come out today to put these kits together. Thank you all. Thanks so much. I am very happy to be here today to be with all of you as we put these kits together for World
- Aethlon Medical Releases Shareholder Letter
- Business Wire - September 4, 2008
- SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, September 2008 will be a pivotal month for our organization as we expect to initiate the first clinical use of our Hemopurifier(R) in HIV-infected
- M A C AIDS Fund, Fergie Spearhead Global Youth Initiative for HIV Prevention
- Business Wire - September 4, 2008
- -- Multi-Million Dollar Campaign Aimed at Combatting Skyrocketing HIV Infection Rate among 15-24-Year-Olds NEW YORK--Yesterday, in New York City, M A C VIVA GLAM VI spokesperson, Fergie, announced 11 new grants from the M A C AIDS Fund (MAF) aimed at preventing the spread of HIV among young people, ages 15-24, who acco
- Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS
- Business Wire - September 4, 2008
- MELBOURNE, Australia--Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS. The product i
- Press Availability by the First Lady
- Business Wire - September 2, 2008
- MINNEAPOLIS--Crowne Plaza Hotel St. Paul, Minnesota September 1, 2008 8:41 A.M. CDT Q Tell me the challenge of balancing this convention with what s going on in the Gulf Coast. MRS. BUSH: Well, I think, you know, we ll just see how it goes. Obviously everybody here understands. I mean, people are disappointed, the dele
- Walter Reed Evaluation Concludes OraQuick(R) HCV Test is Preferred Over Other Rapid Tests
- Business Wire - September 2, 2008
- - OraQuick(R) HCV Test Found to Have Higher Sensitivity and Specificity Than Other Rapid HCV Tests - BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that an evaluation by the Walter Reed Army Institute of Research of the OraQuick(R) HCV Test, currentl
- Remarks by President Bush and President Kikwete of the United Republic of Tanzania after Meeting
- Business Wire - August 29, 2008
- WASHINGTON--Oval Office 11:50 A.M. EDT PRESIDENT BUSH: It is such an honor to welcome a man I ve come to admire a lot to the Oval Office, President Kikwete of Tanzania . He comes representing a great country. He also comes representing the African Union. And therefore, we ve had a wide-ranging discussion about our bila
- California Law to Compel Insurers to Cover Routine HIV Tests Is First in Nation
- Business Wire - August 29, 2008
- -- AB 1894 (Krekorian, D-Burbank), Will Advance Fight Against HIV/AIDS in California -- Following CDC s Recent Announcement of Alarming 40% Annual Increase in HIV Incidence in the US, Legislation Will Help Communities Meet CDC s Previous 2006 Guidelines Recommending Routine HIV Testing in Clinical and Health Care Setti
- Maxygen Receives $3.4 Million Government Grant to Develop Vaccine Discovery Technology
- Business Wire - August 27, 2008
- REDWOOD CITY, Calif. -- Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, today announced that it has been awarded a 2-year, $3.4 million grant from the United States Department of Defense1 to develop technology to advance vaccine research and development. Under
- AHF Blasts GlaxoSmithKline Print Ads That Promote Fear of HIV Treatment
- Business Wire - August 25, 2008
- As Reported in Today s Wall Street Journal, AHF Says Recent GSK Ad Campaign is Attempt to Maintain Market Share without Regard for Patient Health; Asks HHS to Step Up Oversight in Light of FDA s Failure to Do So LOS ANGELES -- AIDS Healthcare Foundation (AHF), the largest non-profit AIDS healthcare provider in the
- Minnesota AIDS Project Highlights the Need for a National HIV Prevention Strategy at the Republican and Democratic National Conventions - Will distribute safer sex kits at local bars with education information included during RNC
- Business Wire - August 25, 2008
- MINNEAPOLIS -- Contrary to what many Americans may believe, AIDS is a growing public health threat not only overseas, but right here at home. Over the next two weeks, political leaders from both parties will discuss a variety of important issues facing the United States . The Minnesota AIDS Project, the leading source
- Greenberg Glusker Attorney Rachel Wilkes Lauded for Pro Bono Asylum Victory - Undeterred Greenberg Glusker Attorney Prevents Deportation of Abuse Victim to Mexico
- Business Wire - August 22, 2008
- LOS ANGELES -- As a result of the determination of a young Greenberg Glusker litigator, a physical and sexual abuse victim facing grave danger if returned to her native Mexico obtained an order from a U.S. Immigration judge granting asylum in the United States . The ruling is the outcome of a multijurisdictional, ye
- BioAlliance Pharma Announces the Grant of Its Main Patent on The Lauriad(R) Technology in Europe
- Business Wire - August 22, 2008
- The patent has been validated in the main European countries and the opposition period has now expired PARIS -- Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced the grant of its main patent on
- LinkMed: Qiagen launches Olerup SSP AB's new test for detecting adverse reactions to HIV-medicine in the EU
- Business Wire - August 22, 2008
- LinkMed s wholly owned subsidiary Olerup SSP AB has developed a new test that detects genetic variations in the Human Leucocyte Antigen (HLA) system that indicate risk for severe adverse reactions to Abacavir in HIV patients. The test is marketed and sold by Qiagen. Experts expect more tests for similar markers in the
- Tegan Quin and Augusten Burroughs Co-Headline Housing Works Benefit for SPIN.com Sept 4, in NYC
- Business Wire - August 21, 2008
- -- New Tegan and Sara Video on the Way; Tegan to Appear in Against Me! Video BURBANK, Calif.--As previously reported, singer/songwriter Tegan Quin from acclaimed Canadian band Tegan and Sara and author Augusten Burroughs (Running With Scissors; A Wolf at the Table) will co-headline SPIN.com s Liner Notes, an event at H
- Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at Prestigious IHV Meeting
- Business Wire - August 19, 2008
- Team Welcomes Attendees to Poster Session to Discuss Findings, Which Could Lead to Inexpensive, Effective HIV Therapy, and May Be Applicable to Autoimmune Diseases AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theor
- ProLink Announces Promotional and Event Partnerships with River Oaks US Men's Clay Court Championship; and Elton John & Billie Jean King Charity Event
- Business Wire - August 19, 2008
- -- Firm to Launch Nationwide Series Following US Open featuring Sampras, Navratilova, Roddick, Kournikova, Bryan Brothers and More AUSTIN, Texas--ProLink Sports + Entertainment + Media (ProLink) announced today that it will serve as an event partner for two of tennis premier events: the 2008 World Team Tennis All-Star
- iTherX Pharmaceuticals Appoints Scientific and Clinical Advisory Board for Hepatitis C Antiviral Drugs
- Business Wire - August 9, 2008
- SAN DIEGO--iTherX Pharmaceuticals Inc, a privately held biopharmaceutical company, today announced that it has appointed a Scientific and Clinical Advisory Board to assist the company in the development of its novel therapeutic agents for Hepatitis C. iTherX is pioneering the introduction of a novel class of antivirals
- Mattel Children's Foundation Continues Signature Partner Collaboration with Total Donation of $2.1 Millon to Six Charities
- Business Wire - August 18, 2008
- -- Mattel commits 2 percent of annual pre-tax profit to global philanthropic giving. EL SEGUNDO, Calif.--Highlighting a tradition of making a meaningful difference in the lives of children, Mattel, Inc. [NYSE: MAT] today announced the continuation of its commitment to the company s six Signature Partners. In 2008, Matt
- Shuyuan Zhang Joins VIRxSYS as Senior Director of Production
- Business Wire - August 18, 2008
- GAITHERSBURG, Md.--VIRxSYS Corporation announced today that Shuyuan Zhang, PhD, has joined the company as Senior Director of Production. Zhang will focus on the development and late stage GMP manufacture of lentiviral vectors and ex vivo patient CD4 T cell transduction and expansion for HIV treatment. The Company s fir
- Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles: inancial Capital Markets M.A.D. MAX Equity Conference
- Business Wire - August 15, 2008
- LAKE LAS VEGAS, Nev.--The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson. Listed below are the Noble Financial Capital Markets M.A.D. MAX Equity Conference presenter profiles. For in-depth information about the event, visit
- 224,000 Californians Sign Petition Urging the Governor and Legislature to Rescind Medi-Cal Cuts: Medi-Cal Patients Are Losing Access to Needed Medication
- Business Wire - August 14, 2008
- SACRAMENTO, Calif.--The ten percent Medi-Cal provider cuts that went into effect on July 1, 2008 have already created hardships throughout California for pharmacists and the patients they serve. More and more pharmacies have been forced to stop filling Medi-Cal prescriptions because pharmacies lose money on nearly ever
- amfAR Announces Appointment of Bradley Jensen as New CFO
- Business Wire - August 14, 2008
- -- With extensive experience in global finance, Jensen will help the foundation expand its international presence NEW YORK--amfAR, The Foundation for AIDS Research, has appointed Bradley Jensen as its new chief financial officer, amfAR CEO Kevin Robert Frost announced today. Jensen comes to amfAR from the Global Allian
- Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)
- Business Wire - August 14, 2008
- BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, has reported initial positive safety data from its Phase IIb/IIIa clinical study of RPI-78M for treating
- Inovio Biomedical Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research
- Business Wire - August 14, 2008
- -- DNA Vaccine Delivery Technology Shows Promise in Inducing Stronger Immune Responses SAN DIEGO--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today it has expanded its research license with the
- Gamma Mu Foundation Awards $129,550 in Gay & Lesbian Community Service Grants and Scholarships
- Business Wire - August 13, 2008
- NEW YORK--Gamma Mu Foundation today announced the award of more than $129,000 in community service & public education grants and scholarships in support of their mission of making the world a more hospitable place for people regardless of sexual orientation, gender identity or health status. The awards serves multi
- Bill to 'Revolutionize' HIV Testing Passes California Legislature Unanimously
- Business Wire - August 12, 2008
- -- AB 2899 (Portantino, D-Pasadena), Sponsored by AIDS Healthcare Foundation (AHF), Overhauls Counseling Model for HIV Testing Programs; Bill Eliminates Outdated One Size Fits All Approach for More Prudent Public Health Approach SACRAMENTO, Calif.--AIDS Healthcare Foundation (AHF), the operator of the largest non-gover
- One(R) Condoms Challenges Presidential Candidates to Get in Bed with Condoms
- Business Wire - August 12, 2008
- -- Company Delivers More Than 100,000 Condoms to Campaigns; Encouraging Distribution in Support of Comprehensive Sexual Education BOSTON--In response to a recent report by the Centers for Disease Control regarding a sharp increase in HIV infection rates in the United States , One(R) Condoms has issued a bold challenge
- Dicerna Pharmaceuticals' Co-founders Publish Studies Describing Novel Approaches to Maximizing Dicer-Substrate Small Interfering RNAs (DsiRNAs)
- Business Wire - August 12, 2008
- CAMBRIDGE, Mass.--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), today announced key studies highlighting the therapeutic potential for Dicer-substrate small interfering RNAs (DsiRNAs). Th
- Inhibitex Reports Second Quarter 2008 Financial Results and Highlights
- Business Wire - August 12, 2008
- ATLANTA--Inhibitex, Inc. (NASDAQ:INHX) today announced its financial results for the second quarter ended June 30, 2008. We are pleased and encouraged by the measurable progress we have made in all three of our core antiviral development programs during the first half of 2008, most notably the clinical advancement of o
- U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
- Business Wire - August 11, 2008
- - Important New Treatment Option for Millions in United States Affected by Life-Threatening Liver Disease - FOSTER CITY, Calif.-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration ( FDA ) has granted marketing approval for
- Allion Healthcare to Present at Noble Financial Equity Conference
- Business Wire - August 11, 2008
- MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Fourth Annual Noble Financial Equity Conference at 8:3